Navigation Links
HELEX Septal Occluder

ProductsHELEX Septal Occluder
Company W. L. Gore & Associates, Inc.
Item HELEX Septal Occluder
Features 
Description Open heart surgery is no longer the only available option to correct atrial septal defects in young children and in patients with complicating health factors. Today's health care providers are seeking non-surgical options to close inter-atrial defects.

The GORE HELEX Septal Occluder is a permanently implanted prosthesis and catheter delivery system indicated for the transcatheter closure of ostium secundum atrial septal defects (ASDs).

The Occluder, which is composed of ePTFE patch material supported by a Nitinol wire frame, bridges and eventually occludes the septal defect to stop the shunting of blood between the atria. The process of tissue ingrowth and attachment to the patch creates a permanent defect closure.

Info W. L. Gore & Associates, Inc.
Customer Service: (800) 437-8181

Related medicine products :

1. CARDIA Atrial Septal Defect Closure Device
2. Goffman Occluder
3. Frosted Long Handle Occluder
4. Long Handle Occluder - Black
5. Long Handle Occluder - White
6. Black Multi-Pinhole Occluder
7. Lorgnette Pinhole Occluder
8. Maddox Rod and Occluder
9. Lombart Clip-on Occluder
10. Lombart Clip-on Pinhole Occluder
11. Occluder and Maddox Rod
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products:
(Date:12/8/2016)... ... , ... David J. Dykeman , Ginger Pigott , and ... at DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg ... global Life Sciences & Medical Technology Group have been featured speakers at every DeviceTalks ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... 10.2 version gives development continuity to its innovative Unified Instance Manager architecture, ... capacity. In addition, this new version optimizes the unattended auto-dialing system without ...
(Date:12/8/2016)... ... December 08, 2016 , ... STAT courier is pleased to ... convenient service for Texas, they are expanding their presence in Dallas. One of the ... that will bring new jobs to the Dallas and Forth Worth market. STAT takes ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... and the Affordable Care Act. Dr. Botelho advocates for the mass media launching ... movement gives people ongoing opportunities to share their unfortunate experiences; such a movement ...
(Date:12/8/2016)... ... December 08, 2016 , ... The ... from offices headquartered in Hamilton County, is embarking on a charity drive with ... in finding new homes for orphaned or neglected senior dogs in the Cincinnati ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016 Australia Glaucoma Surgery Devices ... new report, "Australia Glaucoma Surgery Devices Market Outlook ... Australia Glaucoma Surgery Devices market. The report provides ... units) and average prices (USD) within market segement ... provides company shares and distribution shares data for ...
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... to grow in 2017-2023. Various reasons for growth of ... population, higher incidences of chronic diseases, high recovery cost ... aid services. Medical lifting sling refers to an ... limited mobility. These slings connect to the lift and ...
(Date:12/8/2016)... Dec. 8, 2016  Eli Lilly and Company (NYSE: ... its phase 3 EXPEDITION3 trial at the 9 th ... previously disclosed, solanezumab did not meet the primary endpoint ... initiated in people with mild dementia due to Alzheimer,s ... for solanezumab for the treatment of mild dementia due ...
Breaking Medicine Technology: